172@29@17@245!~!172@29@0@53!~!|news|india|uttarakhand-ayurved-dept-to-issue-notice-to-ramdevs-patanjali-for-launching-covid-19-medicine-5449851.html?src=interim_read!~!news|moneycontrol|com!~!|controller|infinite_scroll_article.php!~!is_mobile=false
Moneycontrol
Subscribe to PRO at just Rs.33 per month. Use code SUPERPRO
you are here: HomeNewsIndia
Last Updated : Jun 25, 2020 12:17 PM IST | Source: Moneycontrol.com

Patanjali's Coronil: “We only approved license for immunity booster," says licence officer

The licensing authority of the Uttarakhand government has been requested to provide copies of licence and product approval details of the Ayurvedic medicines being claimed for the treatment of coronavirus infection, the AYUSH ministry said.

The Uttarakhand Ayurved Department will issue a notice to yoga guru Ramdev's Patanjali Ayurved, asking how they got permission to make the kit of medicines for the treatment of COVID-19, reported news agency ANI citing the Licence Officer of the department.

Ramdev's herbal medicine company Patanjali Ayurved has launched 'Coronil tablet and Swasari vati' medicines claiming they can cure the highly contagious disease within seven days.

It has also claimed that the two Ayurveda-based medicines have shown 100 percent favourable results during clinical trials on COVID-19 infected patients except those on a life support system.

Close

After the launch of the medicine on June 23, The AYUSH ministry has asked Patanjali Ayurved to provide at the earliest details of the name and composition of the medicines being claimed for coronavirus infection treatment, information on sites or hospitals where the research study was conducted and the protocols followed, the AYUSH ministry said.

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

Follow our LIVE blog for the latest updates of the novel coronavirus pandemic

Patanjali has also been asked to provide information on sample size, details of the Institutional Ethics Committee clearance, CTRI registration, results data of the study and "stop advertising/publicizing such claims till the issue is duly examined".

The licensing authority of the Uttarakhand government has been requested to provide copies of licence and product approval details of the Ayurvedic medicines being claimed for the treatment of coronavirus infection, the ministry said in its statement.

Asked about the issue, Uttarakhand Ayurved Department said Patanjali did not mention coronavirus while applying for the licence. “We only approved license for immunity booster, cough and fever. We'll issue them a notice asking how they got permission to make the kit (for COVID19),” the Licence Officer told ANI.

Earlier, the ministry had written to state licensing authorities or drug controllers advising them to take action against any misleading information, false claims and misbranding. The directive said that false claims and publicising approval of research study or product manufacturing about COVID-19 control, writing COVID-19 related claims and name of the ministry of AYUSH on the labels and containers tantamount to contravention of legal provisions.

(With inputs from PTI)

Follow our full coverage on COVID-19 here.
First Published on Jun 24, 2020 03:18 pm
Sections